Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|October 9, 2001
Selective estrogen-receptor modulators in 2001R M O'Regan, W J Gradishar
Seminars in Oncology|June 13, 2001
Tamoxifen to raloxifene and beyondR M O'Regan, V C Jordan
Endocrine-Related Cancer|May 28, 2004
Farnesyl transferase inhibitors: the next targeted therapies for breast cancer?R M O'Regan, F R Khuri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2000
Rapid development of tamoxifen-stimulated mutant p53 breast tumors (T47D) in athymic miceJ M Schafer, E S Lee, R M O'Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
Effects of the new selective estrogen receptor modulator LY353381.HCl (Arzoxifene) on human endometrial cancer growth in athymic miceR C Dardes, D Bentrem, R M O'Regan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic miceK Yao, E S Lee, D J Bentrem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic miceE S Lee, J M Schafer, K Yao, et al.
Breast Cancer (Tokyo, Japan)|October 9, 2008
Laboratory models of breast and endometrial cancer to develop strategies for antiestrogen therapyR M O'Regan, G M England, J I Macgregor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
Analysis of cross-resistance of the selective estrogen receptor modulators arzoxifene (LY353381) and LY117018 in tamoxifen-stimulated breast cancer xenograftsJ M Schafer, E S Lee, R C Dardes, et al.
Journal of the National Cancer Institute|October 28, 1998
Effects of the antiestrogens tamoxifen, toremifene, and ICI 182,780 on endometrial cancer growthR M O'Regan, A Cisneros, G M England, et al.
Pageof 2